# People Using GLP-1s Like Ozempic and Wegovy Exercise Less, New Research Shows
People taking GLP-1 receptor agonists like Ozempic and Wegovy are exercising less than they did before starting the medications, according to new research. This trend emerges despite growing evidence that combining these drugs with physical activity produces better health outcomes.
The drugs work by mimicking glucagon-like peptide-1, a hormone that regulates appetite and blood sugar. They've become popular for weight loss and diabetes management. However, the reduced exercise rates among users raise concerns about long-term health benefits.
Researchers tracking GLP-1 users found that many people decreased their physical activity after beginning treatment. Some reported feeling less motivated to exercise, while others cited fatigue or gastrointestinal side effects that made workouts uncomfortable. The pattern holds true across different age groups and fitness levels.
This matters because exercise provides benefits beyond weight loss. Physical activity strengthens the cardiovascular system, improves bone density, enhances mental health, and reduces the risk of chronic diseases. Studies consistently show that people who combine GLP-1 therapy with regular exercise lose more weight and maintain their results longer than those relying on medication alone.
The appeal of GLP-1 drugs lies partly in their effectiveness without lifestyle changes. Patients lose weight without major dietary overhauls or fitness commitments. This convenience may inadvertently reduce exercise motivation, creating a false sense that medication alone delivers optimal results.
Doctors prescribing GLP-1 drugs should explicitly encourage continued or increased exercise. Some patients benefit from guidance on managing medication side effects during workouts. Starting with low-intensity activities like walking or swimming, then gradually increasing intensity, helps people maintain fitness while taking these medications.
GLP-1 therapy remains valuable for weight loss and metabolic health. But treating it as